Patent - Abbreviated New Drug Application Cases filed in New Jersey
Cases 41 - 50 of 788
FRESENIUS KABI USA LLC v. ACCORD HEALTHCARE INC.
as 2:2024cv05674
Plaintiff: FRESENIUS KABI USA LLC
Defendant: ACCORD HEALTHCARE INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
IMPAX LABORATORIES, LLC v. ASCENT PHARMACEUTICALS INC.
as 1:2024cv05299
Plaintiff: IMPAX LABORATORIES, LLC
Defendant: ASCENT PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MERCK SHARP & DOHME B.V. et al v. HIKMA PHARMACEUTICALS USA INC.
as 2:2024cv03206
Plaintiff: MERCK SHARP & DOHME B.V. and MERCK SHARP & DOHME LLC
Defendant: HIKMA PHARMACEUTICALS USA INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AMERICAN REGENT, INC. v. RK PHARMA, INC.
as 2:2024cv01169
Plaintiff: AMERICAN REGENT, INC.
Defendant: RK PHARMA, INC., VGYAAN PHARMACEUTICALS LLC, APICORE US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
IMPAX LABORATORIES, LLC v. ASCENT PHARMACEUTICALS INC.
as 2:2024cv05299
Plaintiff: IMPAX LABORATORIES, LLC
Defendant: ASCENT PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. et al
as 3:2024cv04317
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: HETERO USA, INC., HETERO LABS LTD. UNIT-V and HETERO LABS LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
IPSEN BIOPHARMACEUTICALS, INC. et al v. CONJUPRO BIOTHERAPEUTICS, INC. et al
as 3:2024cv04991
Plaintiff: IPSEN BIOPHARMACEUTICALS, INC. and IPSEN BIOPHARM LTD.
Defendant: CONJUPRO BIOTHERAPEUTICS, INC., CSPC PHARMACEUTICAL GROUP LIMITED and CSPC OUYI PHARMACEUTICAL CO., LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. ALKEM LABORATORIES LTD.
as 3:2024cv04312
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: ALKEM LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
INTRA-CELLULAR THERAPIES, INC. v. AUROBINDO PHARMA LTD. et al
as 3:2024cv04264
Plaintiff: INTRA-CELLULAR THERAPIES, INC.
Defendant: AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BEIGENE USA, INC. et al v. SANDOZ INC.
as 3:2024cv01972
Plaintiff: BEIGENE USA, INC. and BEIGENE SWITZERLAND GMBH
Defendant: SANDOZ INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?